An experimental inhaled therapy called LAM-001 significantly reduced symptom severity for all patients who completed a small Phase 2a clinical trial for pulmonary hypertension with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension. “These findings are encouraging for patients and the broader pulmonary hypertension community and support continued development…

Using artificial intelligence (AI) analyses of clinical data from hundreds of patients, scientists have created a new system to calculate the risk of future clinical worsening in people with pulmonary arterial hypertension (PAH). “To our knowledge, this is the first study to use machine learning to leverage existing [electronic…

Living with a rare disease like pulmonary hypertension (PH) brings sudden, overwhelming changes. If you or a loved one recently received a diagnosis, you likely know the intense emotional weight that follows. Fear, stress, and anxiety frequently accompany the physical symptoms in those early days. Because May…